Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps NHS England is taking to increase access to NICE-approved treatments for patients with inflammatory skin conditions.
The National Institute for Health and Care Excellence (NICE) evaluates all new licensed medicines and licence extensions for existing medicines including any treatments for inflammatory skin conditions and aims to issue guidance on their use close to the time of licensing wherever possible. The National Health Service in England is legally required to fund medicines recommended by NICE, normally within 90 days of the publication of its final guidance. NICE has recommended a number of treatments for inflammatory skin conditions such as eczema, hidradenitis suppurativa and psoriasis that are now routinely available for NHS patients.